Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON57865Not yet recruiting
Randomised, open-label trial of furosemide and bumetanide in heart failure (HF) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Disease-related quality of life. Planned start Jul 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON57865.